Hjem › Endokrine sygdomme › Texas › Houston
Endokrine sygdomme kliniske forsøg i Houston, TX
6 studier for Endokrine sygdomme søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RekruttererFase 3
- Ascendis Pharma Investigational Site, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruttererFase 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
Study of BHV-1300 in Graves' Disease
RekruttererFase 1
- Site-106, Houston
- Site-101, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Rare and Atypical Diabetes Network
RekruttererObservationsstudie
- Baylor College of Medicine, Houston
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
RekruttererObservationsstudie
- University of Texas MD Anderson Cancer Center, Houston
Endokrine sygdomme forsøg i andre byer
- Washington, DC5 studier
- Chicago, IL4 studier
- Miami, FL3 studier
- San Antonio, TX3 studier
- Seattle, WA3 studier
- Boston, MA3 studier
- New York City, NY3 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.